CLEAR CELL ENDOMETRIAL CANCER

Clinical trials for CLEAR CELL ENDOMETRIAL CANCER explained in plain language.

Never miss a new study

Get alerted when new CLEAR CELL ENDOMETRIAL CANCER trials appear

Sign up with your email to follow new studies for CLEAR CELL ENDOMETRIAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Immunotherapy hope for rare cancers: new trial targets tumors ignored by big pharma

Disease control Recruiting now

This study tests the drug nivolumab in people with rare advanced cancers that have a specific marker (PD-L1). Participants must have tried standard treatments without success. The goal is to see if the drug can shrink or control tumors for at least a short time, offering a new op…

Matched conditions: CLEAR CELL ENDOMETRIAL CANCER

Phase: PHASE2 • Sponsor: Instituto do Cancer do Estado de São Paulo • Aim: Disease control

Last updated May 07, 2026 18:39 UTC

CLEAR CELL ENDOMETRIAL CANCER

Get alerted when new CLEAR CELL ENDOMETRIAL CANCER trials appear

Immunotherapy hope for rare cancers: new trial targets tumors ignored by big pharma